NEW YORK (GenomeWeb) – Danaher today priced its $2 billion offering of senior notes. 

The firm said that it anticipates net proceeds of $1.98 billion from the offering, which will be used to repay part of the commercial paper issued to finance a portion of Danaher's recent $13.8 billion acquisition of Pall

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.